High Ground Investment Management LLP Boosts Position in Humana Inc. (NYSE:HUM)

Key Points

• High Ground Investment Management LLP increased its stake in Humana Inc. by 1.4%, now owning approximately 430,498 shares, which constitutes about 26.6% of their investment portfolio.
• Institutional investors hold a significant portion of Humana's stock, totaling 92.38%, with major increases in positions from other hedge funds like Dodge & Cox and GAMMA Investing LLC.
• Market analysts have set a consensus target price of $282.43 for Humana, with ratings ranging from "hold" to "buy" from various brokerages.

High Ground Investment Management LLP raised its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 1.4% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 430,498 shares of the insurance provider's stock after acquiring an additional 6,095 shares during the period. Humana makes up about 26.6% of High Ground Investment Management LLP's investment portfolio, making the stock its 2nd largest position. High Ground Investment Management LLP owned 0.36% of Humana worth $113,910,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Dodge & Cox lifted its position in shares of Humana by 106.7% during the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock valued at $2,587,345,000 after buying an additional 5,264,045 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Humana by 40,881.1% during the first quarter. GAMMA Investing LLC now owns 781,099 shares of the insurance provider's stock valued at $2,066,790,000 after buying an additional 779,193 shares during the last quarter. Southpoint Capital Advisors LP acquired a new position in shares of Humana during the fourth quarter valued at about $190,282,000. 8 Knots Management LLC purchased a new position in shares of Humana in the 4th quarter valued at approximately $145,258,000. Finally, Invesco Ltd. raised its position in shares of Humana by 29.8% in the 4th quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock valued at $608,348,000 after purchasing an additional 550,692 shares during the last quarter. Institutional investors own 92.38% of the company's stock.

Analysts Set New Price Targets

Several brokerages recently commented on HUM. Barclays set a $268.00 price objective on shares of Humana and gave the company an "equal weight" rating in a research report on Thursday, June 12th. Mizuho upped their price objective on shares of Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Wells Fargo & Company set a $348.00 price objective on shares of Humana in a report on Friday, July 18th. Robert W. Baird dropped their price objective on shares of Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a research note on Friday. Finally, Wall Street Zen raised shares of Humana from a "hold" rating to a "buy" rating in a research note on Sunday, July 20th. Sixteen analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, Humana presently has an average rating of "Hold" and a consensus target price of $282.43.

Humana Price Performance

Shares of NYSE HUM opened at $231.25 on Tuesday. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.71. Humana Inc. has a twelve month low of $206.87 and a twelve month high of $406.09. The stock has a 50 day moving average of $234.25 and a two-hundred day moving average of $255.84. The stock has a market cap of $27.91 billion, a P/E ratio of 16.35, a P/E/G ratio of 1.63 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, topping the consensus estimate of $10.07 by $1.51. The business had revenue of $32.11 billion during the quarter, compared to analysts' expectations of $32 billion. Humana had a return on equity of 14.47% and a net margin of 1.42%. The company's quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $7.23 earnings per share. On average, research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.